Friday 29 November 2024

Pharma & Biotech Start-up & Scale-up News

Featured

Acadia Pharmaceuticals
Acadia Pharmaceuticals (Nasdaq: ACAD) is a leading pharmaceutical company with a focus on bringing life-changing therapies to patients suffering from CNS diseases.
Pharmaceutical
Lexicon pivots back to pipeline after FDA rejection
25 November 2024
Pharmaceutical
The week in pharma: action, reaction and insight – week to November 1
3 November 2024

Latest Ones To Watch News

Biotechnology
Beijing’s Allink secures $42 million in series A
29 November 2024
Biotechnology
Acadia signs deal with Saniona for SAN711 rights
28 November 2024
Pharmaceutical
PDUFA target action date for Soleno’s DCCR extended by three months
27 November 2024
More ones to watch news >
Reset all filters
Refine Search
Enanta Pharmaceuticals
Basilea
Basilea
Exsilio Therapeutics
Aphaia Pharma
Avextra
Aurion Biotech
āshibio
UTILITY Therapeutics
Enlaza Therapeutics
Jacobio Pharma
SFA Therapeutics
Reunion Neuroscience
Atopia Therapeutics
Prologue Medicines
Lykos Therapeutics
Attovia Therapeutics
Ajax Therapeutics
Cartesian Therapeutics
AltruBio
Progentos Therapeutics


Today's issue

Enhertu added to China's health insurance plan
Biotechnology
Enhertu added to China's health insurance plan
29 November 2024
Biotechnology
More positive data for Shanghai’s Minghui
29 November 2024
Biotechnology
Beijing’s Allink secures $42 million in series A
29 November 2024
Biotechnology
Innovent updates on Sintbilo in China
29 November 2024
Pharmaceutical
Denmark to permanently legalize medical cannabis
29 November 2024
Pharmaceutical
Doxycycline risk not found but action on Veoza
29 November 2024
Pharmaceutical
Formosa inks deal with Medvisis for clobetasol rights
29 November 2024

Company Spotlight

Acadia Pharmaceuticals (Nasdaq: ACAD) is a leading pharmaceutical company with a focus on bringing life-changing therapies to patients suffering from CNS diseases.




Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze